Pharmacy

Electronic mail address associated with a specific drug formulation type in pharmacy or PBM systems. Used to route compounding inquiries, formulary update notifications, or manufacturer alerts tied to a specific drug preparation record in EHR or drug database tables.

Date on which a specific drug formulation type is no longer active or available within pharmacy, PBM, or formulary management systems. Used to enforce prescribing rules, flag expired formulation records, and support historical drug data queries in EHR and claims pipelines.

The time at which a drug formulation process, infusion, or preparation activity was completed. Commonly used in inpatient pharmacy and IV compounding workflows to document when a medication preparation concluded, supporting infusion tracking, nursing administration records, and compounding audit logs.

The identifier of the pharmacist, pharmacy technician, or clinical staff member who created or submitted the drug formulation record into the pharmacy or clinical system. Used in audit trails to establish accountability for compounded preparation documentation, formulary additions, and medication order entry.

The ethnic background classification associated with a patient for whom a drug formulation was prepared or prescribed. Used in pharmacy research, pharmacogenomics studies, and population health analytics to assess medication response patterns and health equity metrics across patient demographic groups.

Validity end date for a drug preparation type in pharmacy dispensing, PBM, or formulary systems, indicating when the formulation is no longer approved for dispensing or reimbursement. Critical for drug master file validation and claims adjudication logic in healthcare data pipelines.

A reference identifier assigned to a drug formulation by an external system, such as a pharmacy benefit manager, drug database vendor, or interfacing EHR platform. Used to cross-reference and reconcile formulation records across disparate healthcare and pharmacy systems during data integration and interoperability processes.

The facsimile number associated with transmitting a drug formulation order or compounding specification to a pharmacy, prescriber, or external facility. Used in pharmacy communication workflows where electronic prescribing is unavailable, particularly for controlled substance prescriptions requiring physical or faxed documentation.

The charge assessed for preparing or dispensing a specific drug formulation, including compounding labor, ingredient costs, and dispensing fees. Used in pharmacy billing and revenue cycle management to calculate the total cost of custom drug preparations submitted to payers or billed directly to patients.

The primary or abbreviated name element used to identify a drug formulation within pharmacy systems, often reflecting the base active ingredient or brand name component. Used in formulary displays, medication reconciliation interfaces, and clinical decision support tools to present drug preparations in a recognizable format.

Binary status marker in pharmacy or PBM drug master tables indicating whether a specific drug preparation type meets a defined clinical, formulary, or regulatory condition. Used to filter or trigger downstream processing logic in EHR, claims adjudication, and prior authorization workflows.

The prescribed administration schedule specifying how often a drug formulation is to be given, such as once daily, twice daily, or every eight hours. Used in pharmacy dispensing, medication order management, and clinical documentation to ensure accurate dosing instructions are communicated to patients and care teams.

The complete standardized name of a drug formulation including the active ingredient, strength, dosage form, and route of administration. Used in formulary management, pharmacy labeling, clinical documentation, and regulatory reporting to unambiguously identify a specific drug preparation across all healthcare systems.

The biological sex or gender classification of the patient for whom a drug formulation was specifically prepared or indicated. Used in pharmacotherapy dosing algorithms, hormone-based compounding specifications, and pharmacy analytics to ensure gender-appropriate drug preparation and support population-level prescribing pattern analysis.

The blood sugar level for a drug preparation type. Used in healthcare data management and clinical workflows. This field is commonly used in electronic health records (EHR), healthcare information systems (HIS), and clinical data warehouses for formulation management and reporting.

The insurance group plan identifier associated with coverage for a specific drug formulation, used during pharmacy claims adjudication to determine applicable formulary tier, cost-sharing, and benefit rules. Links the dispensed preparation to the correct employer group or health plan for accurate reimbursement processing.

The blood hemoglobin level for a drug preparation type. Used in healthcare data management and clinical workflows. This field is commonly used in electronic health records (EHR), healthcare information systems (HIS), and clinical data warehouses for formulation management and reporting.

Unique alphanumeric key assigned to a specific drug preparation type in pharmacy, PBM, or drug reference databases such as Medi-Span or First Databank. Used to link prescribing, dispensing, and claims records across EHR, formulary, and pharmacy benefit management systems.

Ordinal position assigned to a drug preparation type within a sequence or ranked list in pharmacy or formulary reference data systems. Used in drug database integrations such as First Databank or Medi-Span to maintain sort order and support indexed lookups across drug master tables.

Boolean or coded field in pharmacy or PBM drug master data that designates whether a specific drug preparation type meets a particular clinical, formulary, or regulatory criterion. Used in claims adjudication, formulary tiering logic, and EHR drug decision support rule engines.